About Apella
Apella is a company based in San Francisco (United States) founded in 2021 by Jordan Tuttle and Cameron Marlow. It operates as a AI-as-a-Service and HealthTech. Apella has raised $101 million across 2 funding rounds from investors including Casdin Capital, Vensana Capital and PFM Health Sciences. The company has 34 employees as of December 31, 2022. Apella offers products and services including Apella Horizon. Apella operates in a competitive market with competitors including Caresyntax, ClearPoint Neuro, Cydar Medical, Perfint Healthcare and MediView, among others.
- Headquarter San Francisco, United States
- Employees 34 as on 31 Dec, 2022
- Founders Jordan Tuttle, Cameron Marlow
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$101 M (USD)
in 2 rounds
-
Latest Funding Round
$80 M (USD), Series B
Jan 08, 2026
-
Investors
Casdin Capital
& 9 more
-
Employee Count
34
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Apella
Apella offers a comprehensive portfolio of products and services, including Apella Horizon.
AI-powered platform optimizing surgical schedules and capacity.
People of Apella
Unlock access to complete
Funding Insights of Apella
Apella has successfully raised a total of $101M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $80 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Apella
Apella has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Casdin Capital, Vensana Capital and PFM Health Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Locked | Locked | Locked | |
|
Investments in medical technology are made by Vensana Capital.
|
Locked | Locked | Locked | |
|
Healthcare companies are invested in by this private equity firm.
|
Locked | Locked | Locked |
Investor details for Apella
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Apella
Investment portfolio details for Apella
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Apella
Detailed financials for Apella
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Apella Comparisons
Peer comparison for Apella
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Apella
Apella operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Caresyntax, ClearPoint Neuro, Cydar Medical, Perfint Healthcare and MediView, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Surgical outcomes are enhanced via analytics and integration platform.
|
|
| Locked | Locked | Locked |
Software and hardware solutions for MRI-guided surgical planning are provided.
|
|
| Locked | Locked | Locked |
Surgical images are analyzed via AI for endovascular procedures.
|
|
| Locked | Locked | Locked |
Solutions for image-guided interventional procedures are developed.
|
|
| Locked | Locked | Locked |
Digital medical images are managed for healthcare providers.
|
Detailed competitors of Apella
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Apella
Complete news archive for Apella
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apella
Apella was founded in 2021.
Apella is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Apella is a funded company, having raised a total of $101M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Apella is 34.
Apella is engaged in providing AI-driven solutions for operating room optimization within the healthcare sector. The platform integrates with electronic health records to deliver real-time data and analytics, enabling surgical teams to enhance scheduling, reduce delays, and increase capacity. Solutions are designed to improve workflow efficiency, automate administrative tasks, and support better patient care outcomes through data-driven insights and predictive scheduling tools.
Apella's top competitors include Caresyntax, ClearPoint Neuro and VitVio.
Apella offers Apella Horizon.
Apella has 10 investors. Key investors include Casdin Capital, Vensana Capital, PFM Health Sciences, Twine Ventures, and Upside Partnership.